Telomir reports Telomir-1 induces near-complete tumor cell death in TNBC models; iron-rescue confirms mechanism

Telomir Pharmaceuticals, Inc.

Near-complete tumor cell mortality in MDA-MB-468 (Basal-A/EGFR-high) TNBC cells at 72h.
Significant partial reduction in HCC70 (Basal-like) and MDA-MB-231 (Claudin-low) cells.
Supplemental iron attenuated Telomir-Zn-induced mortality, supporting iron-dependent mechanism.
Prior zebrafish xenograft showed reduced growth/metastasis; IND submission expected Q1 2026.
GLP safety studies in rats/dogs showed no adverse toxicity; IND-enabling activities ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.